Full Alliance Group, Inc. (OTCPK: FAGI), Announces Addition of Dr. P Brian Volpp to its Board of Directors
May 16 2017 - 7:50AM
InvestorsHub NewsWire
Full
Alliance Group, Inc. (OTCPK:
FAGI), Announces Addition of Dr. P Brian Volpp to its Board of
Directors.
Alta Loma, CA -- May 16, 2017 -- InvestorsHub NewsWire
--
Full Alliance Group, Inc (OTCPK:
FAGI), a multinational holding company, is pleased to announce
that Dr P Brian Volpp has been named to its Board of Directors.
Dr. P Brian Volpp, MD, MPH, is currently Medical Director of San
Diego Radiosurgery and practices full-time as a board-certified
radiation oncologist at various hospitals throughout San Diego
County. After graduating cum laude from Princeton University, where
he also won the Kellogg and Kafer Trophies as a four-year varsity
letter winner on the baseball team, Dr Volpp continued on
academically to obtain both his MD as well as an MPH in
Administration. He is has published and presented research
internationally and is currently primary investigator in a study
looking at the role of radiosurgery for treating prostate
cancer.
Dr. Volpp also gained board certification by the American Board of
Holistic Medicine and is a proponent of integrating alternative
medications into conventional Western medicine as he cares for his
cancer patients. His immediate task will be to guide management and
the advisory board in solidifying its strategic partnership with
the Native American tribes in both our bio-dynamic and medicinal
cannabis grow businesses. Additionally, He will advise management
on current acquisition negotiations that will add multiple revenue
producing products to the FAGI's holdings.
“Dr. Volpp’s knowledge and experience in oncology and research,
along with his formal business acumen, will be a great contribution
in the future of the company as it continues with its reformulation
of the neutraceutical line with CBD oil,” said Jacob Thomas,
current Chairman of the Board. “His utility should be more
substantial looking ahead, however, as the company has targeted
several other medically-related projects and acquisitions. Tapping
into Dr Volpp’s skill set should prove particularly beneficial to
the company during this expansion. We will continue to put together
a strong management team that we feel will positively impact
shareholder value in both short and long term.”
Jacob Thomas
Chairman of the Board
FORWARD-LOOKING
STATEMENTS
This shareholder update may contain a
number of forward-looking statements. Words and variations of words
such as: "expect”, "goals", “could”, "plans", "believe",
“continue", "may", "will" and similar expressions are intended to
identify our forward-looking statements, including but not limited
to: our expectation for growth, benefits from brand-building, cost
savings and margins.
These forward-looking statements are subject to a
number of risks and uncertainties, many of which are beyond our
control, which could cause our actual results to differ materially
from those indicated in our forward-looking statements. Such
factors include, but are not limited to: continued volatility of,
and sharp increase in: costs/pricing actions, increased
competition, risks from operating internationally, consumer
weakness, weakness in economic conditions and tax law
changes.
Full Alliance (PK) (USOTC:FAGI)
Historical Stock Chart
From Oct 2024 to Nov 2024
Full Alliance (PK) (USOTC:FAGI)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about Full Alliance Group Inc (PK) (OTCMarkets): 0 recent articles
More Full Alliance Group, Inc. (PC) News Articles